Publikasi Scopus 2023 per tanggal 31 Oktober 2023 (754 artikel)

Hartomuljono A.; Sugiarto A.; Jennefer
58174749600; 57189612291; 58174749700
Hemoperfusion techniques using Jafron HA330 cartridge combined with BBraun Dialog+ dialysis machine in patient with coronavirus disease 2019 pneumonia and septic shock: a case report
2023
Journal of Medical Case Reports
17
1
156
0
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
Hartomuljono A., Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Sugiarto A., Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Jennefer, Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
Background: The use of hemoperfusion for cytokine removal and inflammatory mediators is increasingly intense, especially in coronavirus disease 2019 patients who are already known to the general public for having cytokine storms. However, we have known about these cytokine storms for a long time in the critical care world. One of the modalities to remove cytokines is to use filtration and adsorption techniques with continuous renal replacement therapy. The use of continuous renal replacement therapy is usually constrained by its very high cost compared with standard care, especially in Indonesia, where health costs are covered by national health insurance. In this case, we use hemodialysis and hemoperfusion, using a dialysis machine, which is more cost-effective and easy to use. Case presentation: We used the Jafron HA330 cartridge, modified for the BBraun Dialog+ dialysis machine. This case report presents an 84-year-old Asian man with septic shock due to pneumonia, congestive heart failure, and acute chronic kidney disease accompanied by fluid overload. After undergoing hemodialysis and hemoperfusion separately, there was a gradual and significant clinical improvement. Clinical indicators, including the vasopressor inotropic score and infection markers, should all be considered when deciding whether to begin hemodialysis and hemoperfusion. Conclusion: In general, using hemoperfusion to treat septic shock patients can reduce the length of stay in the intensive care unit, and morbidity and mortality. © 2023, The Author(s).
Chronic kidney disease; COVID-19; Hemodialysis; Hemoperfusion; Septic shock
Aged, 80 and over; COVID-19; Cytokine Release Syndrome; Hemoperfusion; Humans; Male; Pneumonia; Renal Dialysis; Shock, Septic; amino terminal pro brain natriuretic peptide; antibiotic agent; C reactive protein; chloride; creatinine; dexamethasone; dobutamine; furosemide; hemoglobin; heparin; meropenem; moxifloxacin; noradrenalin; piperacillin plus tazobactam; procalcitonin; remdesivir; sodium; urea; vancomycin; vasopressin; adult respiratory distress syndrome; aged; antibiotic therapy; apathy; Article; Asian; ataxic aphasia; bilateral pneumonia; blood flow velocity; brain disease; case report; central venous pressure; chronic kidney failure; clinical article; computer assisted tomography; congestive heart failure; cost effectiveness analysis; COVID-19 pneumonia; crackle; diabetes mellitus;
BioMed Central Ltd
17521947
37029429
Article
Q3
284
15666